Beauty Launchpad
NOVEMBER 22, 2024
Marylle Koken, renowned Sebastian Top International Artist, iconic celebrity stylist and well-established salon owner, has been named Sebastian Professional’s Los Angeles Creative Ambassador.
Alison Bladh
NOVEMBER 22, 2024
As women navigate perimenopause and menopause, hormonal shifts often bring a range of challenging physical and emotional symptoms. One critical hormone in this transition is cortisol, often called the "stress hormone." While cortisol plays an essential role in our body’s natural functions, its interplay with oestrogen and progesterone during menopause can exacerbate stress and discomfort.
Texas Dermatology
NOVEMBER 22, 2024
For individuals struggling with unwanted hair all over the body, it can be a time-consuming and expensive hassle for both men and women. This is why full body laser hair removal may be an ideal solution for anyone wanting smooth, hair-free skin. Wouldn’t it be nice to say goodbye to constant shaving, waxing or other temporary methods? Texas Dermatology offers cutting-edge laser hair removal technology, designed to deliver safe, effective and long-lasting results for the entire body.
Dermatology Times
NOVEMBER 22, 2024
Christopher Bunick, MD, PhD, discusses the multifactorial nature of chronic hand eczema, the burden of severe symptoms, and how delgocitinib restores skin integrity by targeting JAK/STAT pathways.
The Dermatology Digest
NOVEMBER 22, 2024
Christopher Sayed, MD, a Dermatologist at the University of North Carolina Chapel Hill’s HS Clinic in Durham, NC, discusses the role that bimekizumab-bkzx may play for adults with moderate-to-severe hidradenitis suppurativa (HS) now that it has the U.S. Food and Drug Administration’s nod for this chronic inflammatory skin condition. The post What Does the Approval of Bimekizumab-bkzx (Bimzelx, UCB) Mean for the HS Community?
Dermatology Times
NOVEMBER 22, 2024
Panelists discuss how age restrictions for PDE4 inhibitors affect treatment decisions for pediatric patients with atopic dermatitis, addressing parental concerns and highlighting the benefits of a single treatment option like roflumilast for managing overlapping inflammatory dermatologic conditions; they also explore current guidelines for corticosteroid use, the potential impact of PDE4 inhibitors on these guidelines, and the future of topical PDE4 inhibitors in dermatology, including the integ
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
NOVEMBER 22, 2024
The LIBERO study confirmed brodalumab is effective in managing psoriasis in patients over 100 kg, showing comparable long-term benefits in patients under 100 kg.
Beauty Launchpad
NOVEMBER 22, 2024
A new YouGov poll reveals the personal factors that shape U.S. consumers hair care choices.
Dermatology Times
NOVEMBER 22, 2024
Review insights from a premier dermatology event with expert sessions, hands-on insights, and networking to elevate clinical practice.
Dermatology Times
NOVEMBER 22, 2024
Researchers found the TYK2 inhibitor deucravacitinib offers superior efficacy to apremilast and comparable outcomes to biologics.
Dermatology Times
NOVEMBER 22, 2024
Pediatric melanoma, though rare, is the deadliest skin cancer in children, with 300-500 US cases annually.
Dermatology Times
NOVEMBER 22, 2024
Andrea Rosik, MS, PA-C, provides insights into managing challenging cases of atopic dermatitis.
Dermatology Times
NOVEMBER 22, 2024
These findings further suggest the implications of acne vulgaris treatment on the skin barrier.
Expert insights. Personalized for you.
52 
Let's personalize your content